|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 29/00 | |
| A61K 9/127 | |||
| A61K 31/196 | |||
| A61K 31/407 | |||
| A61K 31/5415 |
| (11) | Number of the document | 2632553 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11837126.9 |
| Date of filing the European patent application | 2011-10-27 | |
| (97) | Date of publication of the European application | 2013-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/058169 |
| Date | 2011-10-27 |
| (87) | Number | WO 2012/058483 |
| Date | 2012-05-03 |
| (30) | Number | Date | Country code |
| 407872 P | 2010-10-28 | US |
| (72) |
GARCIA, Louie, Daniel, US
ZHU, Liangjin, US
LAMBERT, William, Joseph, US
PATOU, Gary, US
|
| (73) |
Pacira Pharmaceuticals, Inc.,
10450 Science Center Drive, San Diego, CA 92121,
US
|
| (54) | A SUSTAINED RELEASE FORMULATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG |
| A SUSTAINED RELEASE FORMULATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG |